Functional Brands Enters into Agreement to Acquire Alchemy, a Gold-Backed Blockchain Settlement Platform, in a $142.9 Million Transaction
Lake Oswego, Oregon--(Newsfile Corp. - May 22, 2026) - Functional Brands Inc. (NASDAQ: MEHA) ("Functional Brands" or the "Company") today announced the execution of a definitive agreement for the acquisition of assets from BullionFX, including its Alchemy technology platform; a vertically integrated, gold-backed blockchain settlement layer and decentralized finance (DeFi) ecosystem targeting retail, institutional, and blockchain markets (the "Acquired Assets"). The transaction is valued at $1
Produits ménagers / de consommation / cosmétiques, Santé
2026-05-22 9:00 AM EDT | Functional Brands Inc.
Edison Issues Report on Aamal Company (AHCS)
London, United Kingdom--(Newsfile Corp. - May 22, 2026) - Edison issues report on Aamal Company (QSE: AHCS). Aamal Company's Q126 results showed a softer start to FY26, with pressure concentrated in Trading and Distribution rather than across the wider portfolio. Group revenue declined 19.9% y-o-y to QAR464.8m and attributable net profit fell 11.0% to QAR90.7m, mainly reflecting weaker healthcare-related demand due to a shift towards generic medicines and a more competitive pharmaceutic
Services bancaires / financiers, Matériel informatique, Logiciels, Santé
2026-05-22 4:48 AM EDT | Edison Group
Promino Announces Closing of Final Tranche of Private Placement
Burlington, Ontario--(Newsfile Corp. - May 21, 2026) - Promino Nutritional Sciences, Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) ("Promino" or the "Company"), a performance nutrition company focused on clinically validated amino acid formulations, announces that, further to its press releases dated March 13, April 22, May 5, May 15 and May 20, 2026, the Company has closed its final tranche (the "Final Tranche") of its private placement, issuing an aggregate of 3,000,000 un
Aliments / boissons, Sports, Santé
2026-05-21 6:20 PM EDT | Promino Nutritional Sciences, Inc.
Optimi Health Announces Closing of Oversubscribed US$15 Million Public Offering
Vancouver, British Columbia--(Newsfile Corp. - May 21, 2026) - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company focused on manufacturing and distributing finished psychedelic drug products, today closed its previously announced underwritten public offering (the "Offering") in connection with the uplisting of its common shares to the Nasdaq Capital Market. The Company issued 2,400,000 common s
Biotechnologies, Pharmaceutique, Santé, Psychédéliques
2026-05-21 1:07 PM EDT | Optimi Health Corp.
Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"
Reno, Nevada--(Newsfile Corp. - May 21, 2026) - Conexeu Sciences Inc. (Nasdaq: CNXU) ("Conexeu" or the "Company"), a biotechnology company advancing tissue regeneration, announced it has officially commenced trading on the Nasdaq today under the ticker symbol "CNXU." The Company currently has 25,269,996 shares on an issued and outstanding basis and 35,238,222 shares on a fully diluted basis.
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-05-21 12:02 PM EDT | Conexeu Sciences Inc.
Britannia Life Sciences Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - May 21, 2026) - Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") today provides a corporate update on its current asset position, strategic direction, and capital markets initiatives. The Board of Directors has approved a refined corporate strategy which repositions Britannia as a public market "venture builder and company accelerator." Separately, the Board has also approved the commencement of a normal course issuer bid (the "NCIB")
Biotechnologies, Produits ménagers / de consommation / cosmétiques, Santé, Fournisseurs de services auxiliaires liés au cannabis
2026-05-21 9:08 AM EDT | Britannia Life Sciences Inc
Restart Life Sciences Closes Dedicated Purchase Order Financing Private Placement; CEO Subscribes for 50% of Offering
Vancouver, British Columbia--(Newsfile Corp. - May 21, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that it has successfully closed its previously announced non-brokered private placement offering (the "Offering") of units (the "Units") to establish a revolving purchase order ("PO") financing source for its wholly owned subsidiary, Holy Crap Foods Inc. ("Holy Crap"). The Company has issued a total
Technologies, Biotechnologies, Santé
2026-05-21 6:00 AM EDT | Restart Life Sciences Corp.
Promino Announces Closing of Third Tranche of Private Placement
Burlington, Ontario--(Newsfile Corp. - May 20, 2026) - Promino Nutritional Sciences, Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) ("Promino" or the "Company"), a performance nutrition company focused on clinically validated amino acid formulations, is pleased to announce that, further to its press releases dated March 13, April 22, May 5 and May 15, 2026, the Company has closed a third tranche (the "Third Tranche") of its private placement, issuing an aggregate of 10,206,66
Aliments / boissons, Sports, Santé
2026-05-20 8:07 PM EDT | Promino Nutritional Sciences, Inc.
Adia Med Now Recruiting for Kidney Health and Lower Back Pain Studies Listed on ClinicalTrials.gov
Winter Park, Florida--(Newsfile Corp. - May 20, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine, today announced that its subsidiary Adia Med of Winter Park LLC is now actively recruiting participants for two key clinical studies officially listed as "Recruiting" on ClinicalTrials.gov.
Soins de santé et hôpitaux, Santé
2026-05-20 11:58 AM EDT | Adia Nutrition Inc.
Orange Auto Insurance, Inc., Subsidiary of HPN Holdings, Inc. Appoints William Raniere as Executive Vice President of Claims & General Counsel
Chicago, Illinois--(Newsfile Corp. - May 20, 2026) - HPN Holdings, Inc. (OTCID: KICK) ("HPN" or the "Company") today announced that its subsidiary, Orange Auto Insurance, Inc ("Orange"), a technology-driven non-standard automobile insurance managing general agency, has appointed William Raniere as Executive Vice President of Claims & General Counsel. Mr. Raniere joins Orange with decades of leadership experience across the automobile insurance, claims, litigation, and legal industri
2026-05-20 9:00 AM EDT | HPN Holdings, Inc.
Sym Sciences Awarded $50,000 Grant to Advance IND-Ready Cannabinoid Research Platform
New York, New York--(Newsfile Corp. - May 20, 2026) - Sym Sciences announced today that it has been awarded a $50,000 grant from the to support the development of standardized, IND-ready cannabinoid materials for clinical research. The funding will enable Sym Sciences to expand its university research network and accelerate the preparation of regulatory-grade cannabinoid formulations designed for NIH-funded studies. The initiative is focused on streamlining the pathway from product deve
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-05-20 8:25 AM EDT | Sym Sciences
Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting
Vancouver, British Columbia--(Newsfile Corp. - May 20, 2026) - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company focused on manufacturing and distributing finished psychedelic drug products, today announced the pricing of its underwritten public offering (the " Offering") in connection with the uplisting of its common shares to the Nasdaq Capital Market. The Company is offering 2,400,000 common shares at a public o
Biotechnologies, Pharmaceutique, Santé, Psychédéliques
2026-05-20 8:00 AM EDT | Optimi Health Corp.
Optimi Health gibt Preisfestsetzung für überzeichnetes öffentliches Angebot in Höhe von 15 Mio. US-$ und Nasdaq-Uplisting bekannt
Vancouver, British Columbia--(Newsfile Corp. - Mittwoch, 20. Mai 2026) - Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (das "Unternehmen" oder "Optimi"), ein pharmazeutisches Unternehmen im kommerziellen Stadium mit Fokus auf die Herstellung und den Vertrieb fertiger psychedelischer Arzneimittelprodukte, gab heute die Preisfestsetzung seines gezeichneten öffentlichen Angebots (das "Angebot") im Zusammenhang mit dem Uplisting seiner Stammaktien an den Nasdaq Capital Market bek
Biotechnologies, Pharmaceutique, Santé, Psychédéliques
2026-05-20 8:00 AM EDT | Optimi Health Corp.
PreveCeutical Announces Extension of Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - May 19, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases dated May 12, 2026 and April 22, 2026, it has extended the closing of its private non-brokered private placement (the "Offering") of units of the Company (each, a "Unit") to raise gross proceeds of $1,000,000 to June 12, 2026 and intend
Biotechnologies, Pharmaceutique, Santé
2026-05-19 7:36 PM EDT | PreveCeutical Medical Inc.
NorthPalm Capital Launches as AI-Augmented Investment Company
Toronto, Ontario--(Newsfile Corp. - May 19, 2026) - NorthPalm Capital Corp. (CSE: NP) ("NorthPalm" or the "Company") is pleased to announce the launch of NorthPalm Capital[1], an AI-augmented investment company focused on identifying and supporting high-growth opportunities across technology and digital asset sectors. The launch reflects NorthPalm's evolution into a leaner, high-conviction investment company with a modern approach to sourcing, evaluating, and act
Biotechnologies, Soins de santé et hôpitaux, Santé
2026-05-19 8:36 AM EDT | NorthPalm Capital Corp.
UBERDOC Health Technologies Announces Appointment of John Dvor to Board of Directors
Boston, Massachusetts--(Newsfile Corp. - May 19, 2026) - UBERDOC Health Technologies (CSE: APPT) (FSE: 4KL0) is pleased to announce the appointment of John Dvor to its Board of Directors as the company continues to scale its nationwide direct-pay specialty care marketplace and expand strategic partnerships in advanced medical services and technologies. John Dvor brings deep experience and extensive relationships across medical innovation, healthcare technology, advanced therap
2026-05-19 8:30 AM EDT | Apptly Health Technologies Corp.
Conexeu Sciences Advances 3D Biofabricated Matrix to Move Breast Reconstruction Beyond Implants
Reno, Nevada--(Newsfile Corp. - May 19, 2026) -
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-05-19 8:30 AM EDT | Conexeu Sciences Inc.
Edison Issues Report on Alkemya Metacore
London, United Kingdom--(Newsfile Corp. - May 19, 2026) - Edison issues report on Alkemya Metacore. The Alkemya Metacore token offers exposure to trade and investment activities in high-technology metals with a particular focus on ultra-pure nickel and its specialised applications. The core asset of c 7m linear metres of 99.99% purity 0.025mm diameter nickel wire has been independently valued at $1.64bn. Not intended for persons in the US and only for qualified investors
Services bancaires / financiers, Matériel informatique, Logiciels, Santé
2026-05-19 7:56 AM EDT | Edison Group
Neural Portfolio Company Hanf.com Expands German Retail Footprint with New Muhldorf am Inn Store and Four Refurbished Locations
Toronto, Ontario--(Newsfile Corp. - May 19, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic solutions for mental health conditions related to substance use disorders, together with its portfolio company CWE European Holdings Inc. ("CWE"), operating as Hanf.com, one of Germany's leading CBD retailers, is pleased to announce the opening of a new Hanf.
Biotechnologies, Pharmaceutique, Santé, Psychédéliques
2026-05-19 7:30 AM EDT | Neural Therapeutics Inc.
QScreen AI Appoints Former Pentagon Joint Artificial Intelligence Center Director Lt. Gen. Michael S. Groen (Ret.) to Advisory Board Following Live Platform Demonstration
Toronto, Ontario--(Newsfile Corp. - May 19, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or "QAI"), an innovator in physiological AI screening, today announces the appointment of Lieutenant General Michael S. Groen (Ret.) to its Advisory Board. Lt. Gen. Groen is the former Director of the Joint Artificial Intelligence Center (JAIC) at the US Department of Defense. Lt. Gen. Groen reviewed the QAI platform during a live demonstration in Toronto prior to confirming
2026-05-19 7:03 AM EDT | QScreen AI Inc.